The dietary supplements industry will have the valuable opportunity to meet with member of Congress, especially new members, during the Natural Products Association’s (NPA; Washington, DC) 14th annual Natural Products Day on Wednesday, April 6.
The dietary supplements industry will have the valuable opportunity to meet with member of Congress, especially new members, during the Natural Products Association’s (NPA; Washington, DC) 14th annual Natural Products Day on Wednesday, April 6.
Attendees will visit congressional offices and talk to Senators, Representatives, and theirstaffs about key legislation that may impact the natural products industry, as well as to educate them about the important preventative role natural products play in keeping Americans healthy.
“Natural Products Day is a great way for industry members to get a foot in the doors of the policymakers who can make a difference. Nothing makes a greater impact on elected officials than a face-to-face meeting with a constituent,” said John Gay, NPA executive director and CEO. “Next year’s event will allow us to share our story with new members of Congress who probably do not fully understand our industry.”
“NPA and the natural products industry must reinforce our existing ties, and seek new allies to strengthen the industry’s position in Congress,” he added.
The event will begin with a morning session led by association and government relations experts talking about effective ways to communicate with legislators and providing updates on key legislation. An end-of-the-day reception will honor those legislators who have worked hard to support initiatives important to the industry.
For more information and updates, visit www.npainfo.org/NPD11.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.